Scotiabank Canada raises AbbVie target price to $320
智通财经2026/10/06 09:27Scotiabank of Canada raised its price target for AbbVie (ABBV.US) from $280 to $320.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley: Space is the "ultimate backyard" for computing power, maintains "Overweight" rating for SpaceX (SPCX.US)
According to Odaily, Morgan Stanley has released a research report maintaining its “Overweight” rating on SpaceX (SPCX.US) and a target price of $300, representing nearly 90% upside from the closing price of $158.96 on October 2. Analyst Adam Jonas and his team put forward a bolder view: space is becoming the ultimate arena where energy is converted into intelligence in the age of AI.
The three major US stock indexes opened higher, with the Nasdaq up 0.6%.
The Dow Jones opened up 0.34%, the Nasdaq rose 0.6%, and the S&P 500 increased by 0.41%. Leading tech stocks saw gains: Super Micro Computer rose 2.58%, Nvidia was up 1.34%, and Microsoft increased by 1.24%. The Nasdaq Golden Dragon China Index edged up 0.02%, while iQIYI fell 1.94% and NetEase dropped 1.58%.
Nike drops by about 1% as Berenberg downgrades its rating to Sell
Nike (NKE.US) dropped by about 1% after Berenberg downgraded its rating to "Sell".
